Association Between Efficacy of Immune Checkpoint Inhibitors and Sex: An Updated Meta-Analysis on 21 Trials and 12,675 Non-Small Cell Lung Cancer Patients

BACKGROUND: Mounting randomized clinical trials have proved that immune checkpoint inhibitors (ICIs) achieved better overall survival (OS) and progression-free survival (PFS) than chemotherapy drugs for advanced non-small cell lung cancer (NSCLC) patients. However, some literatures have indicated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Chongxiang, Zheng, Shuyue, Dong, Huijing, Lu, Xingyu, Zhang, Xu, Zhang, Jingyi, Li, Jia, Cui, Huijuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427763/
https://www.ncbi.nlm.nih.gov/pubmed/34513654
http://dx.doi.org/10.3389/fonc.2021.627016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427763/
https://www.ncbi.nlm.nih.gov/pubmed/34513654
http://dx.doi.org/10.3389/fonc.2021.627016

Ejemplares similares